PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.42%
Negative revenue growth while Insurance - Life median is -0.04%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-1.42%
Negative gross profit growth while Insurance - Life median is -1.42%. Seth Klarman would suspect poor product pricing or inefficient production.
10.82%
EBIT growth of 10.82% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
10.82%
Operating income growth of 10.82% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand.
0.71%
Net income growth below 50% of Insurance - Life median of 6.40%. Jim Chanos would suspect deeper profitability issues.
0.72%
EPS growth below 50% of Insurance - Life median of 3.50%. Jim Chanos would suspect fundamental earnings weakness or heavy dilution.
0.68%
Diluted EPS growth below 50% of Insurance - Life median of 5.07%. Jim Chanos would suspect fundamental profit weaknesses or heavy share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.80%
Negative OCF growth while Insurance - Life median is -15.91%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-14.80%
Negative FCF growth while Insurance - Life median is -17.77%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
101.93%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 21.75%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
68.39%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 24.68%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
304.32%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 20.63%. Joel Greenblatt might see a short-term competitive advantage at play.
58.12%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 9.10% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
-16.63%
Negative 5Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-21.89%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
-11.98%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 10.58%. Seth Klarman might see a fundamental problem if peers maintain growth.
-38.16%
Negative 5Y CAGR while Insurance - Life median is 20.92%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-41.54%
Negative 3Y CAGR while Insurance - Life median is 6.89%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
64.61%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 28.32% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
33.18%
5Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might see disciplined retention of earnings behind outperformance.
54.96%
3Y equity/share CAGR > 1.5x Insurance - Life median of 20.31%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.56%
AR growth of 24.56% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
19.03%
Asset growth exceeding 1.5x Insurance - Life median of 1.93%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
16.24%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
10.70%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
2.90%
SG&A growth of 2.90% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.